Financhill
Buy
55

CORT Quote, Financials, Valuation and Earnings

Last price:
$83.63
Seasonality move :
10.79%
Day range:
$80.38 - $85.16
52-week range:
$49.00 - $117.33
Dividend yield:
0%
P/E ratio:
93.68x
P/S ratio:
13.22x
P/B ratio:
13.65x
Volume:
1.5M
Avg. volume:
865K
1-year change:
61.08%
Market cap:
$8.6B
Revenue:
$675M
EPS (TTM):
$0.88

Earnings Data

Next earnings date for CORT
Feb 25
2026
Most recent earnings per share
$0.16
Beat by $0.03
(Nov 4/2025)
Consensus Estimate
$0.14
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CORT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $261.1M -- -- $0.34 --
11/04/2025 Q3 $218.5M $207.6M $0.16 $0.14 $0.03
07/31/2025 Q2 $199.4M $194.4M $0.29 $0.19 $0.10
05/05/2025 Q1 $177.9M $157.2M $0.17 $0.14 $0.03
02/26/2025 Q4 $200.1M $181.9M $0.26 $0.42 -$0.17
10/30/2024 Q3 $172M $182.5M $0.41 $0.29 $0.12
07/29/2024 Q2 $155.2M $163.8M $0.32 $0.24 $0.08
05/01/2024 Q1 $141.2M $146.8M $0.25 $0.22 $0.03
02/15/2024 Q4 $129.3M $135.4M $0.28 $0.26 $0.03
11/01/2023 Q3 -- -- $0.28 $0.23 $0.05
08/02/2023 Q2 -- -- $0.25 $0.15 $0.10
05/03/2023 Q1 -- -- $0.14 $0.21 -$0.07
02/28/2023 Q4 -- -- $0.14 $0.28 -$0.14
11/03/2022 Q3 -- -- $0.30 $0.28 $0.02
08/03/2022 Q2 -- -- $0.24 $0.28 -$0.04
05/05/2022 Q1 -- -- $0.20 $0.31 -$0.11
02/15/2022 Q4 -- -- $0.26 $0.35 -$0.09
11/03/2021 Q3 -- -- $0.24 -- --
07/29/2021 Q2 -- -- $0.21 $0.17 $0.05
05/06/2021 Q1 -- -- $0.18 $0.19 -$0.01
02/08/2021 Q4 -- -- $0.20 $0.17 $0.03
11/03/2020 Q3 -- -- $0.17 $0.23 -$0.06
08/04/2020 Q2 -- -- $0.23 $0.21 $0.02
05/04/2020 Q1 -- -- $0.25 $0.21 $0.04
02/20/2020 Q4 -- -- $0.24 $0.26 -$0.02
11/07/2019 Q3 -- -- $0.22 $0.21 $0.01
08/01/2019 Q2 -- -- $0.25 $0.19 $0.06
05/09/2019 Q1 -- -- $0.20 $0.18 $0.02
02/25/2019 Q4 -- -- $0.24 $0.21 $0.03
11/01/2018 Q3 -- -- $0.22 $0.21 $0.01
08/09/2018 Q2 -- -- $0.20 $0.24 -$0.04
05/08/2018 Q1 -- -- $0.19 $0.18 $0.02
02/22/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- $0.14 $0.14 --
05/01/2017 Q1 -- -- -- $0.03 --
01/30/2017 Q4 -- -- -- $0.05 --
11/01/2016 Q3 -- -- $0.02 $0.01 $0.01
08/03/2016 Q2 -- -- $0.02 $0.01 $0.01
05/03/2016 Q1 -- -- $0.01 $0.01 --

Corcept Therapeutics, Inc. Earnings Questions

  • How Much did Corcept Therapeutics, Inc. Generate in Revenue Last Quarter?

    Corcept Therapeutics, Inc. reported $207.6M worth of top line sales in its most recent quarter.

  • Did Corcept Therapeutics, Inc. Beat Earnings Last Quarter?

    Corcept Therapeutics, Inc. announced earnings per share of $0.16 which represents a beat of analyst forecast a $0.14 per share.

  • Is Corcept Therapeutics, Inc. Profitable?

    Corcept Therapeutics, Inc. reported $203M that represents $1.70 per share over the last quarter.

  • What is the Analyst Consensus for Corcept Therapeutics, Inc. EPS Next Year?

    Corcept Therapeutics, Inc.'s earnings are forecast to decrease from $1.23 per share to $1.41 per share next year representing a decrease of -21.28%.

  • When is Corcept Therapeutics, Inc.'s Earnings Date?

    Corcept Therapeutics, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock